New Enzyme Aims to Break RNA Sequencing Bottleneck
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
A novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
The latest version introduces a high-powered field of view designed to elevate the diagnostic experience for pathologists, along with a dedicated tumor board workflow module.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The system automates cervical cytology with AI-powered sample preparation, imaging, and analysis...
The collaboration will deploy FDA-cleared slide scanners across anatomic pathology services to support AI integration and address pathologist shortage.
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
The infrared dye antibody conjugates aim to expand human phenotyping experiments innovation and make high-parameter flow cytometry more accessible.
The DX-60 system offers 28 reportable parameters, malaria detection capabilities, and requires minimal sample volumes for testing.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
New instrument features StreamFocus ionization technology and AI-powered intelligence for enhanced sensitivity and efficiency in clinical laboratories.
Research-use-only assay identifies 28 urinary targets and 25 antibiotic resistance markers with same-day turnaround time.
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
The CLIA-waived immunoassay delivers results in as fast as 10 minutes and is designed for physician offices, urgent care centers, and decentralized hospital labs.
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.